Start and compare
What tesamorelin is for
A search result may start with a product name. Begin the care conversation by explaining what you need help with.
A medicine that prompts a body signal
Tesamorelin is lab-made and copies a natural hormone, one of the body’s signals.
It prompts the pituitary, a hormone-making gland, to release growth hormone.
Growth hormone then raises the level of IGF-1, a substance that helps control growth.
The September 2026 label calls for IGF-1 checks during treatment.
The effects of keeping IGF-1 high for a long time are unknown.
Ask how this level would be checked and how a change in belly fat would be judged.
Tesamorelin and growth hormone are different things.
The approved use has a clear boundary
HIV stands for human immunodeficiency virus.
Lipodystrophy describes a changed pattern of body fat.
As of September 2026, U.S. approval covers excess belly fat for adults who have HIV and lipodystrophy.
The September 2026 label, the medicine’s written information, says tesamorelin is not for weight loss.
Body weight barely changed in the main studies of people taking the medicine.
In the U.S., medicines are reviewed by an agency called the Food and Drug Administration (FDA).
Off-label means a use the FDA has not approved for that medicine.
For another goal, ask the clinician what evidence fits that goal and your health history.
Words that help make sense of the visit
- Peptide
In a tesamorelin discussion, peptide refers to protein building blocks linked into a small chain.
- Lipodystrophy
Lipodystrophy describes a changed pattern of body fat.
- Deep belly fat
Deep belly fat sits around organs inside the abdomen.
As of September 2026, a peptide’s name alone cannot establish its safety or legal status.
Weighing care for deep belly fat
Name the goal first. Ask whether the evidence and the labelled use match it.